NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 218 filers reported holding NEVRO CORP in Q3 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $914,000 | +10.4% | 5,516 | -7.0% | 0.00% | 0.0% |
| Q1 2021 | $828,000 | -11.8% | 5,934 | +9.4% | 0.00% | 0.0% |
| Q4 2020 | $939,000 | +129.6% | 5,423 | +84.8% | 0.00% | 0.0% |
| Q3 2020 | $409,000 | +16.9% | 2,935 | +0.1% | 0.00% | – |
| Q2 2020 | $350,000 | +57.0% | 2,932 | -24.9% | 0.00% | – |
| Q3 2018 | $223,000 | -36.5% | 3,906 | -11.2% | 0.00% | -100.0% |
| Q2 2018 | $351,000 | -8.4% | 4,397 | -0.5% | 0.00% | 0.0% |
| Q1 2018 | $383,000 | -81.2% | 4,418 | -85.0% | 0.00% | -75.0% |
| Q4 2017 | $2,040,000 | -28.2% | 29,550 | -5.4% | 0.00% | -33.3% |
| Q3 2017 | $2,840,000 | +9.1% | 31,245 | -10.7% | 0.01% | 0.0% |
| Q2 2017 | $2,603,000 | +0.9% | 34,976 | +27.0% | 0.01% | 0.0% |
| Q1 2017 | $2,581,000 | +22.0% | 27,545 | -5.4% | 0.01% | +20.0% |
| Q4 2016 | $2,116,000 | -29.6% | 29,118 | +1.2% | 0.01% | -37.5% |
| Q3 2016 | $3,004,000 | +42.4% | 28,780 | +0.6% | 0.01% | +14.3% |
| Q2 2016 | $2,110,000 | – | 28,605 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
| Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
| Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
| Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
| ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
| FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
| PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
| FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
| Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
| K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |